Found: 7
Select item for more details and to access through your institution.
Sex differences in migraine attack characteristics: A longitudinal E‐diary study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 333, doi. 10.1111/head.14488
- By:
- Publication type:
- Article
Depression and treatment with anti‐calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16106
- By:
- Publication type:
- Article
Both perimenstrual and nonperimenstrual migraine days respond to anti‐calcitonin gene‐related peptide (receptor) antibodies.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 7, p. 2117, doi. 10.1111/ene.15794
- By:
- Publication type:
- Article
Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!)
- Published in:
- Trials, 2024, p. 1, doi. 10.1186/s13063-024-07955-8
- By:
- Publication type:
- Article
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231198792
- By:
- Publication type:
- Article
Defining migraine days, based on longitudinal E-diary data.
- Published in:
- Cephalalgia, 2023, v. 43, n. 5, p. 1, doi. 10.1177/03331024231166625
- By:
- Publication type:
- Article
Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1387044
- By:
- Publication type:
- Article